Combined Therapy with Anti-PD1 and BRAF and/or MEK Inhibitor for Advanced Melanoma: A Multicenter Cohort StudySandra Huynh, Julie Delyon, M.‐T. Leccia et al.|Cancers|2020Cited by 21